WASHINGTON — The pharmaceutical industry is not lobbying senators to stop the confirmation of long-time critic Robert F. Kennedy Jr. to the top health care
WASHINGTON — Vice President Harris is proposing to use cuts to the pharmaceutical industry’s profits in Medicare to fund a home care benefit for people
WASHINGTON — During the vice presidential debate Tuesday, Republican nominee JD Vance at long last provided a bit more clarity to the Trump campaign’s vague
Rachel Cohrs Zhang Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying,
WASHINGTON — The biotech industry’s largest trade group has parted ways with its top lobbyist, the group confirmed to STAT, adding to a recent bout